Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
- PMID: 34098568
- DOI: 10.1038/s41586-021-03677-y
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Abstract
Following its emergence in late 2019, the spread of SARS-CoV-21,2 has been tracked by phylogenetic analysis of viral genome sequences in unprecedented detail3-5. Although the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, travel within Europe resumed in the summer of 2020. Here we report on a SARS-CoV-2 variant, 20E (EU1), that was identified in Spain in early summer 2020 and subsequently spread across Europe. We find no evidence that this variant has increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant's success. Despite travel restrictions, we estimate that 20E (EU1) was introduced hundreds of times to European countries by summertime travellers, which is likely to have undermined local efforts to minimize infection with SARS-CoV-2. Our results illustrate how a variant can rapidly become dominant even in the absence of a substantial transmission advantage in favourable epidemiological settings. Genomic surveillance is critical for understanding how travel can affect transmission of SARS-CoV-2, and thus for informing future containment strategies as travel resumes.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Update of
- Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020.medRxiv [Preprint]. 2021 Mar 24:2020.10.25.20219063. doi: 10.1101/2020.10.25.20219063.medRxiv. 2021.Update in: Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y.PMID: 33269368Free PMC article.Updated.Preprint.
Similar articles
- Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020.medRxiv [Preprint]. 2021 Mar 24:2020.10.25.20219063. doi: 10.1101/2020.10.25.20219063.medRxiv. 2021.Update in: Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y.PMID: 33269368Free PMC article.Updated.Preprint.
- A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada.Genome Med. 2021 Oct 28;13(1):169. doi: 10.1186/s13073-021-00986-9.Genome Med. 2021.PMID: 34706766Free PMC article.
- Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh.Infect Genet Evol. 2021 Nov;95:105057. doi: 10.1016/j.meegid.2021.105057. Epub 2021 Sep 1.Infect Genet Evol. 2021.PMID: 34481060Free PMC article.
- Fifteen days in December: capture and analysis of Omicron-related travel restrictions.BMJ Glob Health. 2022 Mar;7(3):e008642. doi: 10.1136/bmjgh-2022-008642.BMJ Glob Health. 2022.PMID: 35296466Free PMC article.Review.
- The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment.Int Health. 2021 Sep 3;13(5):383-398. doi: 10.1093/inthealth/ihab037.Int Health. 2021.PMID: 34333650Free PMC article.Review.
Cited by
- COVIDOUTCOME-estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome.Database (Oxford). 2021 May 8;2021:baab020. doi: 10.1093/database/baab020.Database (Oxford). 2021.PMID: 33963845Free PMC article.
- A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.Infect Genet Evol. 2022 Nov;105:105360. doi: 10.1016/j.meegid.2022.105360. Epub 2022 Sep 5.Infect Genet Evol. 2022.PMID: 36070806Free PMC article.
- A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection.Sci Rep. 2021 May 19;11(1):10617. doi: 10.1038/s41598-021-89957-z.Sci Rep. 2021.PMID: 34012108Free PMC article.
- Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23.Nat Methods. 2023.PMID: 36823332Free PMC article.
- Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong.Nat Commun. 2022 Feb 8;13(1):736. doi: 10.1038/s41467-022-28420-7.Nat Commun. 2022.PMID: 35136039Free PMC article.
References
- WHO Emergency Committee. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting... (2020).
- Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020). - DOI
- Worobey, M. et al. The emergence of SARS-CoV-2 in Europe and North America. Science 370, 564–570 (2020). - DOI
- Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018). - DOI
- du Plessis, L. et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science 371, 708–712 (2021). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous